Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Regeneron (REGN)

NASDAQ:REGN

US Market

REGN

Regeneron

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Regeneron (REGN) Stock News & Sentiment

4,704 Followers

Regeneron’s Linvoseltamab Trial: A Potential Game-Changer in Multiple Myeloma Treatment

Company Announcements

Regeneron’s Linvoseltamab Trial: A Potential Game-Changer in Multiple Myeloma Treatment

24h ago

Regeneron’s Gene-Silencing Study for MASH: A Potential Market Game-Changer

Company Announcements

Regeneron’s Gene-Silencing Study for MASH: A Potential Market Game-Changer

24h ago

Regeneron’s Innovative Approach: Linvoseltamab in Multiple Myeloma Study

Company Announcements

Regeneron’s Innovative Approach: Linvoseltamab in Multiple Myeloma Study

24h ago

Regeneron’s New NSCLC Study: Potential Game-Changer in Cancer Treatment?

Company Announcements

Regeneron’s New NSCLC Study: Potential Game-Changer in Cancer Treatment?

24h ago

Regeneron’s Aflibercept Study: A Closer Look at Retinal Vasculitis Incidence

Company Announcements

Regeneron’s Aflibercept Study: A Closer Look at Retinal Vasculitis Incidence

24h ago

Regeneron and Sanofi’s Phase 3 Trial for Itepekimab: A Potential Game-Changer in Chronic Rhinosinusitis Treatment

Company Announcements

Regeneron and Sanofi’s Phase 3 Trial for Itepekimab: A Potential Game-Changer in Chronic Rhinosinusitis Treatment

24h ago

Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Pediatric Prurigo Nodularis

Company Announcements

Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Pediatric Prurigo Nodularis

1d ago

More REGN News >

REGN News on the Web

2025-06-27

EU Approves Bayer's Eylea 8 Mg For Extended 6-Month Dosing In Retinal Diseases

rttnews

Neutral

2025-06-25

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?

Zacks

Neutral

2025-06-24

Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?

Zacks

Neutral

2025-06-23

SPY ETF News, 6/23/2025

TipRanks News

Neutral

2025-06-20

Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid

Zacks

Neutral

2025-06-20

Regeneron, Sanofi: FDA Approves Dupixent To Treat Adult Patients With Bullous Pemphigoid

rttnews

Neutral

2025-06-15

Sanofi : Dupixent Shows Superior Results To Xolair In Phase 4 Study For Sinus And Asthma Treatment

rttnews

Neutral

2025-06-13

Anne Wojcicki to buy back 23andMe and its data for $305 million

CNBC

Neutral

News Score - Last 7 Days

Neutral

REGN

Sector Average

Media Buzz

This Week5 articles

Weekly Average5.5 articles

News Sentiment

This Week50%

Sector Average55%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REGN’s Media Buzz Sentiment?

5 articles about REGN were published this week. In an average week, 5.5 articles are published.

What is REGN’s weekly average amount of articles?

In an average week, 5.5 articles about REGN are published.

What is REGN’s News Sentiment?

50% of articles about REGN were positive this week, compared to its sector average of 55%.

Healthcare Stocks that are Trending in the News

IMCRImmunocore Holdings

EXELExelixis

BSXBoston Scientific

VEEVVeeva Systems

AMNAMN Healthcare Services

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing